20 results
Keyword Aerinaze Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Aerinaze (updated)
desloratadine, pseudophedrine sulfate, Rhinitis, Allergic, Seasonal
Date of authorisation: 30/07/2007, Revision: 20, Authorised, Last updated: 22/11/2021Aerinaze Rhinitis, Allergic Respiratory … assessment report (EPAR) for Aerinaze. It explains how the The committee … the conditions of use for Aerinaze. What is Aerinaze? Aerinaze is a medicine containing … -
List item
Download medicine data (updated)
Last updated: 02/12/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017
European Medicines Agency, London, UK, from 25/09/2017 to 29/09/2017, Last updated: 06/09/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 February 2013
European Medicines Agency, London, UK, from 04/02/2013 to 07/02/2013, Last updated: 02/06/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 March 2017
European Medicines Agency, London, UK, from 06/03/2017 to 09/03/2017, Last updated: 06/03/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2017
European Medicines Agency, London, UK, from 03/07/2017 to 06/07/2017, Last updated: 13/03/2014 -
List item
PRAC: Agendas, minutes and highlights
Last updated: 06/08/2021 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 May 2007
CHMP, Last updated: 25/05/2007medicinal products: Aerinaze (desloratadine 2.5 mg/pseudoephedrine … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 April 2017
European Medicines Agency, London, UK, from 03/04/2017 to 06/04/2017, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2017
European Medicines Agency, London, UK, from 23/01/2017 to 26/01/2017, Last updated: 06/01/2014 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 May 2017
European Medicines Agency, London, UK, from 15/05/2017 to 18/05/2017, Last updated: 06/01/2014 -
List item
PRAC: meeting archive 2012-2013
Last updated: 13/05/2016 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Public data from Article 57 database
Last updated: 02/06/2021 -
List item
Annual reports and work programmes
Last updated: 14/06/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2016
European Medicines Agency, London, UK, from 07/11/2016 to 10/11/2016, Last updated: 06/01/2014 -
List item
Press release: EMEA reports strong performance in regulatory and public-health activities in 2007; the outlook for 2008 is even higher application numbers and a focus on advanced-therapy medicines
Last updated: 10/03/2008 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020